Iqvia acquires remaining interest in q2 solutions from quest diagnostics; raises full year 2021 adjusted diluted eps guidance

Danbury, conn. & research triangle park, n.c.--(business wire)--iqvia holdings inc. (“iqvia”) (nyse:iqv), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced the acquisition of the 40 percent minority share of q2 solutions from quest diagnostics (nyse: dgx), the world leader in diagnostic information services, for $760 million, resulting in 100 percent ownership by iqvia. the transaction has been fi
DGX Ratings Summary
DGX Quant Ranking